Skip to main content
. Author manuscript; available in PMC: 2020 Jun 7.
Published in final edited form as: J Org Chem. 2019 May 24;84(11):6697–6708. doi: 10.1021/acs.joc.9b00385

Table 1.

Percentage inhibition with 0.1 mM of inhibitor using Neu5Acα2–3GalβpNP as the sialidase substrate.

Sialidases Neu5Ac2en 2e3eDFNeu5Ac (1) 2e3eDFNeu5Ac9N3 (2) 2e3eDFNeu5N3 (3) 2e3eDFNeu5Gc (4) 2e3aDFNeu5Ac (5) 2e3aDFNeu5Ac9N3 (6)
A. ureafaciens 95.8±0.6 99.2±0.3 99.9±0.2 75.2±0.2 96.1±0.6 99.9±0.2 99.9±0.1
C. perfringens 72.1±0.0 80.6±0.7 99.9±0.1 29.8±1.2 71.6±1.2 99.9±0.1 99.9±0.1
SpNanA 94.9±2.2 99.7±0.3 85.8±0.7 < 1.0 78.4±0.5 99.9±0.1 99.9 ± 0.1
SpNanB 2.7±0.3 11.8±1.0 26.8±0.2 35.1±0.8 25.3±1.7 12.0±0.2 16.7±1.6
SpNanC 6.3±0.6 < 1.0 < 1.0 < 1.0 < 1.0 < 1.0 < 1.0
V. cholerae 88.2±0.6 97.7±0.3 99.2±0.5 25±1.0 97.8±0.1 96.8±1.4 99.9±0.6
BiNanH2 66.7±1.7 95.4±0.9 98.9±0.0 40.8±3.4 87.3±0.8 98.9±0.5 98.8±2.2
PmST1 2.1±0.8 < 1.0 < 1.0 < 1.0 < 1.0 < 1.0 < 1.0
hNEU2 74.9±0.0 75.4±0.6 82.3±2.8 37.5±1.2 80.4±1.3 69.7±0.4 1.5±0.3